DrugDev
DrugDev's Overview
DrugDev was a technology company dedicated to providing innovative solutions that enhanced the efficiency and collaboration of clinical trials for sponsors, Contract Research Organizations (CROs), and research sites. Its comprehensive platform included tools for study feasibility, site identification and selection, trial master file (TMF) management, site payments, and overall trial optimization. In 2017, DrugDev was acquired by IQVIA (then QuintilesIMS), and its advanced technologies have since been integrated into IQVIA's extensive suite of clinical and commercial solutions. This integration has significantly bolstered IQVIA's capabilities in streamlining clinical development processes and accelerating the delivery of new therapies. DrugDev's core mission was to unify the clinical trial ecosystem through technology.
Where is DrugDev's Headquarters?
HQ Function
Served as the central hub for DrugDev's global operations, including software development, product management, sales, and customer support for its clinical trial technology solutions prior to its 2017 acquisition by IQVIA.
Notable Features:
A modern office facility within a business park, designed to foster a collaborative and innovative environment for a technology-focused workforce. Specific architectural details are not widely publicized.
Work Culture:
DrugDev was known for a dynamic, innovative, and fast-paced work culture. There was a strong emphasis on collaboration and problem-solving, with employees driven by the mission to improve clinical trial processes through technology and make a tangible impact in drug development.
HQ Significance:
The Audubon headquarters was pivotal as the birthplace and operational center for DrugDev's influential clinical trial technology platform. It was where the company grew, innovated, and established its industry leadership before its strategic acquisition by IQVIA.
Values Reflected in HQ: The headquarters' environment likely reflected DrugDev's core values: innovation in technology, a strong customer-centric approach, efficiency in process optimization, and fostering collaboration to solve complex challenges in clinical research.
Location:
Prior to its 2017 acquisition by IQVIA, DrugDev had a significant global reach, supporting clinical trials with its technology solutions for pharmaceutical companies, CROs, and research sites across North America, Europe, and other key international regions. Its platform enabled worldwide collaboration in clinical research, including global site identification, patient recruitment, and trial management. Following the acquisition, these capabilities have been absorbed into IQVIA's extensive global operational network.
Street Address:
920 Cassatt Road, Suite 210
City:
Audubon
State/Province:
Pennsylvania
Country:
USA
DrugDev's Global Presence
London, United Kingdom
Address: Specific street address for the London office pre-acquisition is not widely publicized; it was located in a central business district.
To expand DrugDev's footprint in the European market, manage relationships with regional clients, and support the deployment and adoption of its clinical trial technologies across Europe.
Buying Intent Signals for DrugDev
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of DrugDev
As of April 2025, DrugDev' leadership includes:
Investors of DrugDev
DrugDev has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
As DrugDev was acquired by IQVIA in 2017 and fully integrated, there have been no executive hires or exits for DrugDev as an independent entity in the last 12 months. Leadership and team transitions occurred at the time of the acquisition, with personnel integrated into IQVIA's structure.
Departures
New Appointments:
Technology (Tech Stack) used by DrugDev
Discover the tools DrugDev uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
DrugDev Email Formats and Examples
Prior to its acquisition by IQVIA in 2017, DrugDev likely used common corporate email formats. The most probable formats for the '@drugdev.com' domain would have been variations of [first_initial][last] or [first].[last]. Since the acquisition, the drugdev.com email domain is no longer active, and former employees transitioned to IQVIA's email system (typically @iqvia.com).
[first_initial][last]@drugdev.com or [first].[last]@drugdev.com (historical)
Format
jdoe@drugdev.com or jane.doe@drugdev.com (historical examples)
Example
0 (The drugdev.com email domain is inactive)%
Success rate
News and media
Business Wire (IQVIA Press Release) • July 12, 2017
QuintilesIMS Acquires DrugDev to Strengthen Global Clinical Trial Capabilities and Performance
QuintilesIMS (now IQVIA) announced its acquisition of DrugDev, a leading provider of cloud-based solutions designed to help sponsors, CROs, and sites improve clinical trial processes from site selection to payments. The acquisition aimed to significantly expand QuintilesIMS’s technology-enabled clinical trial capabilities and enhance clinical trial performance for clients....more
PR Newswire • February 2, 2016
DrugDev and Greenphire Announce Strategic Partnership to Streamline Global Investigator Payments
DrugDev and Greenphire, a leader in clinical payment automation, announced a strategic partnership to integrate Greenphire's eClinicalGPS payment technology with the DrugDev platform. This collaboration was aimed at providing a comprehensive, unified solution for managing clinical trial site payments and enhancing financial transparency and efficiency for sponsors and CROs globally....more
Business Wire • October 14, 2015
DrugDev Launches Industry-Standard DrugDev Site Cloud Platform at Global Summit
DrugDev officially launched its DrugDev Site Cloud platform, an integrated suite of site-facing technologies designed to simplify and streamline how investigators and site staff interact with sponsors and CROs. The platform aimed to reduce administrative burden on sites and improve overall trial efficiency....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including DrugDev, are just a search away.